Due to popular demand, I’m re-releasing my short talk from https://realfoodrocks.co.uk/ in the UK. This one compresses so much into such a short time. Big thanks to Dr. David and Jennifer Unwin for an amazing event with ~700 people in attendance in Brathay Hall Estate, Lake District. Due to constraints in the room size, in … Ep118 – Ivor Cummins on Resolving Modern Chronic Disease – at #RFR19! Read More »
The exponential explosion of Covid-19 cases — and it is likely much worse than officially reported, because of inadequate testing and undercounting of cases and deaths — has revealed not just official hubris and incompetence but lack of planning and major deficiencies in the public health system.
A great deal remains that is important to know but that is currently unknown about Covid-19, Eric Zuesse writes.
The eruption of St. Vincent’s La Soufrière (Sulphur) has provided a unique opportunity to push the envelope in matters of mandatory public health policy, notably mandatory vaccination, vaccine passports, and the mass gathering of biometric data.
After fanning COVID panic for a year, Democratic newsletter Salon admits it was all for partisan purposes: “Americans have been sucked into an all-or-nothing approach, with your choice of all or nothing depending largely on your partisan identity.”
While the Global South overprescribes antibiotics, in the West farm animals are pumped full of them, farmers even giving them to healthy animals so they can be packed tighter in ever-increasing herd sizes.
‘Held to Ransom’: Pfizer Plays Hardball in Covid-19 Vaccine Negotiations With Latin American Countries
One of the reasons the government wanted Pfizer’s vaccines was because the company said they could be delivered quickly. Yet in the contract, Pfizer wanted to reserve the right to modify the schedule. There was no room for negotiation. “It was take it or leave it,” said the official.
A viral pandemic cannot succumb by practicing sinister nationalism, by making Russia or China the bogeymen that we all must fear.
The vaccine manufacturers with production facilities in the EU argue that they were under contract to produce vaccines for countries outside the EU (e.g., AstraZeneca for the UK), and that any attempt by Brussels to curb such exports would place them in breach of contract.